Doctors Lounge - Hematology AnswersBack to Hematology Answers List
If you think you may have a medical emergency, call your doctor or 911 immediately. Doctors Lounge (www.doctorslounge.com) does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site.
DISCLAIMER: The information provided on www.doctorslounge.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Please read our 'Terms and Conditions of Use' carefully before using this site.
Date of last update: 10/12/2017.
Forum Name: Hematology Topics
Question: MSD Vidaza
|aitzi - Wed Nov 30, 2005 9:18 am||
My father has been diagnosed witn Mielodispalsia (mielodisplastic sindrome or MSD), we heard vidaza is a medicamente it`s having success in some patients, so we wants to try it, the problem is we live in spain and it,s not available there, so could we just buy it in USA and then be treated in spain with it? where can we get vidaza?
|Dr. Safaa Mahmoud - Wed Jul 26, 2006 2:02 pm||
MDSs is more commonly seen in men above 65years old. Various cytopenias, including anemia, may persist for months to years before the diagnosis is settled.
Dyspoiesis in normocellular or hypercellular bone marrow is the main feature of this disease and include:
Dyserythropoiesis: ineffective erythropoiesis results in anemia and reticulocytopenia; anisocytosis and poikilocytosis
Dysgranulocytopoiesis: Neutropenia; decreased or abnormal neutrophils.
Dysmegakaryocytopoiesis Thrombocytopenia; large platelets with abnormal contents.
Management of MDSs is usually conservative till leukemic transformation.
Supportive care includes packed red blood cell transfusion, platelet transfusion, treatment of infection etc.
Androgens, pyridoxine, folate, and danazol
High doses of erythropoietin (5000 to 10,000 U/day) is helpful in 10% to 20% of patients. Other growth factors
Cytotoxic agents like Low dose cytosar therapy or topotecan showed activity in the treatment of this disease.
Bone marrow transplantation (BMT) should be considered in patients younger than 45 years of age who have an HLA-compatible sibling.
New drugs like Vidaza have shown to be effective in decreasing the transfusion needs and providing better quality of life, however no long term control of the disease could be demonstrated till now.
To read more about Vidaza you can visit our web page:
https://www.doctorslounge.com/oncology/a ... _approval/
|| Check a doctor's response to similar questions|
Are you a Doctor, Pharmacist, PA or a Nurse?
Join the Doctors Lounge online medical community
Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.